Abivax SA (ABVX)
125.76
+4.45
(+3.67%)
USD |
NASDAQ |
Apr 14, 16:00
126.98
+1.22
(+0.97%)
After-Hours: 17:34
Abivax Cash from Investing (TTM) : -15.55M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| AstraZeneca PLC | -7.111B |
| Eli Lilly & Co. | -10.97B |
| DBV Technologies SA | -1.373M |
| Insmed, Inc. | -64.58M |
| Nicox SA | -- |